Azacitidine Injection: Clinical Trials

2 trials of Azacitidine Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow Azacitidine Injection: new trials by email Literature Review of Azacitidine Injection trials Research Report on Azacitidine Injection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Lisaftoclax (APG-2575), Azacitidine Injection, Placebo - Higher-risk Myelodysplastic Syndrome
Phase 3RecruitingAscentage Pharma Group Inc.4902025-01-222026-10-13
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
APG-2575(Lisaftoclax ), Placebo, Azacitidine Injection - Acute Myeloid Leukemia
Phase 3RecruitingAscentage Pharma Group Inc.4862024-06-112025-11-25

Conditions studied

Leukemia, Myeloid, Acute (1)

Sponsors

Ascentage Pharma Group Inc. (2)

Countries

China (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)  ·  Norway (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Guillermo Garcia-Manero, M.D. (1)  ·  Jianxiang Wang, M.D. (1)  ·  Jie Jin, M.D. (1)  ·  Xiaojun Huang, M.D., Ph.D. (1)